Another Controversial Drug Slated for FDA Approval
FDA advisors voted 7-2 in favor of Amylyx Pharmaceutical’s ALS drug known as AMX0035. Meanwhile, these advisors voted 6-4 against the same drug back in March. What accounts for the change in votes and what does this mean for those with ALS? The Deets FDA advisors now back Amylyx’s ALS drug, despite voting against it…
Read MoreOutside the Huddle 9/4/22
1) Dropping the Ball Insuretech company Oscar Health lost a contract with insurance company Health First after failing to implement their product +Oscar on time. The deal would have brought in $60 million in revenue this year. Oscar Health has been posting consistent losses recently, but revenue and membership growth have rapidly increased, and their…
Read MoreBiden Admin Invests $100M into Marketplace Enrollment
The Biden administration is investing a significant $100 million into the Affordable Care Act to increase insurance coverage for underserved communities. Specifically, the funding will go into care navigators, which is expected to increase enrollment as it did so this year. Recall, the ACA marketplace has been riding high following a year of record-breaking enrollment.…
Read More“Do Not Drink the Water”
Thousands of Jackson, Mississippi, residents are without water following water plant failures. No water to shower. No water to flush the toilet. No water to drink. While this may be “breaking news” it certainly isn’t “new” news for Jackson residents. For years, the city has grappled with its broken water system and subsequent public health…
Read MoreOutside the Huddle 8/28/22
1) Can You Hear Me Now? The FDA will now allow patients to purchase hearing aids over the counter, improving access to affordable hearing aids. Patients with perceived hearing loss can now go directly to stores or online shops and purchase hearing aids without needing a full evaluation, prescription or fitting. With an aging population,…
Read MoreThe Medicare Advantage Empire
More than 28 million Americans enrolled in a Medicare Advantage (MA) plan in 2022, representing 48% of all Medicare beneficiaries. MA is attractive for both consumers and insurers: patients reap more benefits like hearing and vision coverage while insurers reap bigger profits. The Deets Out of the 58.6 million Medicare beneficiaries, nearly half are enrolled…
Read More